ImmunoDesigners is developing molecular glues based on a novel, non-Revlimid scaffold. 

These glues aim to facilitate the discovery of neo-substrates while significantly improving the targeting of known disease mechanisms. Additionally, the team is advancing a pseudo virtual in-vitro model (ternary complex model) to elucidate the mechanisms of designed glues and to predict their degradability, driving further innovation in targeted protein degradation.